Founder & CEO of Pre Diagnostics AS, co-founder and Chairman of IC Targets AS. Sæterøy was Executive Chairman of listed company DiaGenic ASA from 2002 – 2010, chairman of Serodus ASA from 2008 – 2012 and chairman/board member of Skannex AS from 2008 – 2014.With 30 years of experience in management, corporate finance and business development, Sæterøy has an extensive international network. He has worked with corporate finance in Norwegian investment banks for 12 years and continued the financing and M&A consultancy business in his own company Investor Corporate AS. Sæterøy has been a shareholder and board member of several life science companies in Norway. He is a board member of Nansen Neuroscience Network (chairman from 2010 – 2012) and was a board member of Oslo Cancer Cluster (2007 - 2014). The Nansen Neuroscience Network (NNN) is founded as an independent organization by industry, academic research groups and clinicians with a particular interest in neuroscience. Oslo Cancer Cluster (OCC) is a Norwegian Centre of Expertise, and Norways leading R&D cluster for Academia, SMBs and large pharma in the oncology area.Sæterøy has a four year programme in economics and business administration consisting of three years at bachelor/undergraduate level and one year at master/graduate level from NHH in Bergen, Norway.